CLINICAL_TRIALS
trial_result
· 2012-09-03
Clinical Trial Update: Anti-Interleukin-1 in Diabetes Action [Phase 2, Phase 3]
Summary
A Phase 2 and Phase 3 clinical trial evaluating an anti-Interleukin-1 therapy for Type 1 Diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Steno Diabetes Center Copenhagen | Conditions: Type 1 Diabetes | Phase 2, Phase 3 | Status: COMPLETED